Malignant Peritoneal Neoplasm Completed Phase 2 Trials for Sunitinib (DB01268)

Also known as: Peritoneal Cancer / Malignant neoplasm of peritoneum, unspecified / Malignant peritoneal neoplasm NOS

IndicationStatusPhase
DBCOND0073968 (Malignant Peritoneal Neoplasm)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00768144Sunitinib in Recurrent and Refractory Ovarian, Fallopian Tube and Peritoneal CarcinomaTreatment